We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONIT
5251
PUT
Onity Group
ONIT
$328M
$583K ﹤0.01%
12,427
+754
+6% +$37.8K
ACBI
5252
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$583K ﹤0.01%
33,098
-5,396
-14% -$92.9K
GCAP
5253
DELISTED
Gain Capital Holdings, Inc.
GCAP
$583K ﹤0.01%
58,264
+47,162
+425% +$338K
COLM icon
5254
CALL
Columbia Sportswear
COLM
$2.94B
$582K ﹤0.01%
8,100
-5,500
-40% -$361K
EME icon
5255
Emcor
EME
$36.9B
$582K ﹤0.01%
7,115
+3,007
+73% +$233K
DXJF
5256
DELISTED
WisdomTree Japan Hedged Financials Fund
DXJF
$582K ﹤0.01%
22,425
-19,190
-46% -$482K
TCX icon
5257
PUT
Tucows
TCX
$126M
$581K ﹤0.01%
8,300
+2,500
+43% +$152K
BNFT
5258
PUT
DELISTED
Benefitfocus, Inc.
BNFT
$581K ﹤0.01%
+21,500
New +$596K
RP
5259
DELISTED
RealPage, Inc.
RP
$581K ﹤0.01%
13,109
-116,890
-90% -$5.1M
PGNX
5260
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$581K ﹤0.01%
97,700
+38,800
+66% +$236K
WWW icon
5261
CALL
Wolverine World Wide
WWW
$1.73B
$580K ﹤0.01%
+18,200
New +$525K
ZAGG
5262
PUT
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$579K ﹤0.01%
+31,400
New +$587K
IAI icon
5263
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.39B
$578K ﹤0.01%
9,208
+908
+11% +$54.2K
PKX icon
5264
CALL
POSCO
PKX
$17.7B
$578K ﹤0.01%
7,400
-9,800
-57% -$725K
AUPH icon
5265
Aurinia Pharmaceuticals
AUPH
$2.06B
$577K ﹤0.01%
127,289
+115,389
+970% +$641K
EQM
5266
CALL
DELISTED
EQM Midstream Partners, LP
EQM
$577K ﹤0.01%
7,900
+3,100
+65% +$222K
PRTK
5267
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$576K ﹤0.01%
32,172
-61,505
-66% -$1.28M
CSOD
5268
CALL
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$576K ﹤0.01%
16,300
-15,300
-48% -$571K
AGQ icon
5269
ProShares Ultra Silver
AGQ
$1.43B
$575K ﹤0.01%
16,979
-23,545
-58% -$783K
CCC
5270
PUT
DELISTED
Calgon Carbon Corp
CCC
$575K ﹤0.01%
27,000
+13,400
+99% +$288K
ARR
5271
PUT
Armour Residential REIT
ARR
$2.37B
$574K ﹤0.01%
4,460
+2,420
+119% +$311K
BIP icon
5272
CALL
Brookfield Infrastructure Partners
BIP
$18.3B
$574K ﹤0.01%
+21,504
New +$557K
IWC icon
5273
CALL
iShares Micro-Cap ETF
IWC
$1.52B
$574K ﹤0.01%
6,000
+100
+2% +$9.48K
TXRH icon
5274
CALL
Texas Roadhouse
TXRH
$13.6B
$574K ﹤0.01%
10,900
-5,700
-34% -$288K
GBL
5275
DELISTED
GAMCO Investors, Inc.
GBL
$574K ﹤0.01%
19,346
+8,863
+85% +$259K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.